Amneal Pharmaceuticals Inc at Raymond James Institutional Investors Conference (Virtual) Transcript
Good afternoon. Welcome to the Amneal Pharmaceuticals virtual presentation at Raymond James Annual Institutional Investor Conference. Pleased to have the company joining us this afternoon. Representing the company, members of management, we have Chirag Patel, company's Co-CEO and Co-Founder; along with Chintu Patel, also company's Co-CEO and a Co-Founder; and Tasos Konidaris, the company's Chief Financial Officer. Amneal is a leading U.S.-based generics company, founded in 2002; now, the fourth largest player in the industry. Has consistently moved up the generics value chain over the past several years, increasingly focused on high barrier to entry, specialty generics, biosimilars and specialty brands.
So thank you, gentlemen. Welcome. I appreciate you joining us this afternoon.
Thank you.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
